Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

United States Anesthesia & Respiratory Devices Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 366 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Anesthesia and Respiratory Devices
3 Healthcare Sector Review
3.1 Healthcare Expenditure
3.2 Healthcare Infrastructure
3.2.1 Healthcare Personnel Data
3.2.2 Healthcare Facilities Data
4 Anesthesia and Respiratory Devices in United States
4.1 Anesthesia and Respiratory Devices Overall Revenues (2000-2012)
4.2 Anesthesia and Respiratory Devices Overall Volumes (2000-2012)
4.3 Anesthesia and Respiratory Devices Overall Company Share (2005-2006)
5 Respiratory Devices in United States
5.1 Respiratory Devices Overall Revenues (2000-2012)
5.1.1 Inhalers Overall Revenues (2000-2012)
5.1.2 Continuous Positive Airway Pressure (CPAP) Overall Revenues (2000-2012)
5.1.3 Nebulizers Overall Revenues (2000-2012)
5.1.4 Ventilators Overall Revenues (2000-2012)
5.1.5 Humidifiers Overall Revenues (2000-2012)
5.1.6 Oxygen Concentrators Overall Revenues (2000-2012)
5.1.7 Resuscitators Overall Revenues (2000-2012)
5.2 Respiratory Devices Overall Volumes (2000-2012)
5.2.1 Inhalers Overall Volumes (2000-2012)
5.2.2 Nebulizers Overall Volume (2000-2012)
5.2.3 Humidifiers Overall Volume (2000-2012)
5.2.4 Ventilators Overall Volume (2000-2012)
5.2.5 Resuscitators Overall Volume (2000-2012)
5.2.6 Continuous Positive Airway Pressure Devices Overall Volume (2000-2012)
5.2.7 Oxygen Concentrators Overall Volume (2000-2012)
5.3 Respiratory Devices Average Price (2000-2012)
5.3.1 Continuous Positive Airway Pressure (CPAP) Devices Average Price (2000-2012)
5.3.2 Inhalers Average Price (2000-2012)
5.3.3 Resuscitators Average Price (2000-2012)
5.3.4 Ventilators Average Price (2000-2012)
5.3.5 Humidifiers Average Price (2000-2012)
5.3.6 Nebulizers Average Price (2000-2012)
5.3.7 Oxygen Concentrator Average Price (2000-2012)
5.4 Respiratory Devices Distribution Share (2005-2006)
5.5 Respiratory Devices Company Share (2005-2006)
6 Respiratory Measurement Devices in United States
6.1 Respiratory Measurement Devices Overall Revenues (2000-2012)
6.1.1 Pulse Oximetry Sensors Overall Revenues (2000-2012)
6.1.2 Capnographs Overall Revenues (2000-2012)
6.1.3 Spirometers Overall Revenues (2000-2012)
6.2 Respiratory Measurement Devices Category Volume (2000-2012)
6.2.1 Pulse Oximetry Sensors Overall Volume (2000-2012)
6.2.2 Capnographs Overall Volume (2000-2012)
6.2.3 Spirometers Overall Volume (2000-2012)
6.3 Respiratory Measurement Devices Average Price (2000-2012)
6.3.1 Pulse Oximetry Sensors Average Price (2000-2012)
6.3.2 Capnographs Average Price (2000-2012)
6.3.3 Spirometers Average Price (2000-2012)
6.4 Respiratory Measurement Devices Distribution Share (2005-2006)
6.5 Respiratory Measurement Devices Company Share (2005-2006)
7 Respiratory Disposables in United States
7.1 Respiratory Disposables Overall Revenues (2000-2012)
7.1.1 Disposable Tracheostomy Tubes Overall Revenues (2000-2012)
7.1.2 Laryngeal Mask Airways (LMAs) Overall Revenues (2000-2012)
7.1.3 Disposable Endotracheal Tubes Overall Revenues (2000-2012)
7.1.4 Disposable Oxygen Masks Overall Revenues (2000-2012)
7.1.5 Oxygen Cannulae Overall Revenues (2000-2012)
7.2 Respiratory Disposables Overall Volume (2000-2012)
7.2.1 Oxygen Cannulae Overall Volume (2000-2012)
7.2.2 Disposable Oxygen Masks Overall Volume (2000-2012)
7.2.3 Disposable Endotracheal Tubes Overall Volume (2000-2012)
7.2.4 Laryngeal Mask Airways (LMAs) Overall Volume (2000-2012)
7.2.5 Disposable Tracheostomy Tubes Overall Volume (2000-2012)
7.3 Respiratory Disposables Average Price (2000-2012)
7.3.1 Disposable Oxygen Masks Average Price (2000-2012)
7.3.2 Oxygen Cannulae Average Price (2000-2012)
7.3.3 Disposable Tracheostomy Tubes Average Price (2000-2012)
7.3.4 Disposable Endotracheal Tubes Average Price (2000-2012)
7.3.5 Laryngeal Mask Airways (LMAs) Average Price (2000-2012)
7.4 Respiratory Disposables Distribution Share (2005-2006)
7.5 Respiratory Disposables Company Share (2005-2006)
8 Anesthesia Machines in United States
8.1 Anesthesia Machines Overall Revenues (2000-2012)
8.2 Anesthesia Machines Category Volume (2000-2012)
8.3 Anesthesia Machines Average Price (2000-2012)
8.4 Anesthesia Machines Distribution Share (2005-2006)
8.5 Anesthesia Machines Company Share (2005-2006)
9 Anesthesia Disposables in United States
9.1 Anesthesia Disposables Overall Revenues (2000-2012)
9.1.1 Anesthesia Circuits Overall Revenues (2000-2012)
9.1.2 Anesthesia Masks Overall Revenues (2000-2012)
9.2 Anesthesia Disposables Overall Volume (2000-2012)
9.2.1 Anesthesia Masks Overall Volume (2000-2012)
9.2.2 Anesthesia Circuits Overall Volume (2000-2012)
9.3 Anesthesia Disposables Average Price (2000-2012)
9.3.1 Anesthesia Circuits Average Price (2000-2012)
9.3.2 Anesthesia Masks Average Price (2000-2012)
9.4 Anesthesia Disposables Distribution Share (2005-2006)
9.5 Anesthesia Disposables Company Share (2005-2006)
10 GE Healthcare Company Profile
10.1 Company Overview
10.2 Business Overview
10.2.1 Products
10.3 Locations And Subsidiaries
10.4 Financial Deals Landscape
10.4.1 GE Healthcare Acquires Image Diagnost International
10.4.2 GE Healthcare Acquires Dynamic Imaging
10.4.3 GE Healthcare And The Medipattern Enter Into An Agreement
10.4.4 Ge Healthcare Signs An Agreement With Nordiag
10.4.5 GE Healthcare And Omron Healthcare Enter Into Distribution Agreement
10.4.6 GE Healthcare Acquires Wave Biotech
10.4.7 PhotoCure enters into licensing agreement with GE Healthcare
10.4.8 GE Healthcare And Awarix Enter Into A Partnership Agreement
10.4.9 Ge Healthcare Signs An Agreement With Applied Biosystems
10.4.10 Ge Healthcare Signs An Agreement With Parker Domnick Hunter
10.4.11 BIOTRONIK Signs An Agreement With GE Healthcare
10.4.12 GE Healthcare To Acquire Whatman
10.4.13 GE Healthcare terminates the acquisition of In vitro diagnostics and Point-of-Care diagnostics businesses of Abbott
10.4.14 Abbott Terminates The Deal To Divest Its Divisions To GE Healthcare
10.5 Recent Developments
10.5.1 Dec 20, 2007: DRAXIMAGE Appoints GE Healthcare As Distributor Of DRAXIMAGE(R) Sestamibi In US
10.5.2 Dec 18, 2007: Confirma Expands Strategic Partnership With GE Healthcare
10.5.3 Oct 10, 2007: GE Healthcare Appoints CTO
10.5.4 Jun 26, 2007: Medipattern Signs Sales And Development Agreement With GE
10.5.5 Jun 01, 2007: I-Flow Forms Strategic Alliance With GE Healthcare
10.5.6 Apr 19, 2007: OMRON, GE Enter Distribution Agreement
10.6 GE Healthcare Pipeline Products
10.6.1 Gemstone CT detector
10.6.2 Vivid e 08
10.6.3 LOGIQ e
10.6.4 Logiq Book XP (Upgradation)
10.6.5 Modified lightSpeed VCT scanner
10.6.6 Responder
11 Cardinal Health, Inc. Company Profile
11.1 Company Overview
11.2 Business Overview
11.2.1 Clinical Technologies and Services
11.2.2 Medical Products and Services
11.2.3 Pharmaceutical Distribution and Provider Services
11.2.4 Pharmaceutical Technologies and Services
11.2.5 Products
11.2.6 History
11.3 Value Chain Analysis
11.3.1 Manufacturing
11.3.2 Product Development
11.3.3 Sales and Marketing
11.4 SWOT Analysis
11.4.1 Cardinal Health, Inc. Strengths
11.4.2 Cardinal Health, Inc. Weaknesses
11.4.3 Cardinal Health, Inc. Opportunities
11.4.4 Cardinal Health, Inc. Threats
11.5 Financial and Operational Review
11.6 Locations And Subsidiaries
11.7 Financial Deals Landscape
11.7.1 Cardinal Health Signs An Agreement With ClearCount Medical Solutions
11.7.2 Cardinal Health And Alliance Boots Forms A Joint Venture
11.7.3 Cardinal Health Signs An Agreement With Hemcon Medical Technologies
11.7.4 Cardinal Health Acquires VIASYS Healthcare
11.7.5 Cardinal Health Sells Its Pharmaceutical Technologies And Services Segment To The Blackstone Group
11.7.6 Platinum Equity Completes Acquisition Of Healthcare Marketing Services Unit From Cardinal Health
11.7.7 Cardinal Health Enters Into Distribution Agreement With Fisher & Paykel
11.7.8 Cardinal Health And Surgicount Enter Into Co-Marketing Agreement
11.7.9 Cardinal Health Acquires Care Fusion
11.7.10 Cardinal Health Acquires Medmined
11.7.11 Cardinal Health Acquires PET Radiopharmaceutical Production Facilities From Regional Nuclear Pharmaceuticals
11.7.12 Cardinal Health Acquires Wholesale Distribution Businesses From F. Dohmen
11.7.13 Cardinal Health Acquires Denver Biomedical
11.7.14 Cardinal Health Signs An Agreement With Eisai
11.7.15 Cardinal Health Enters Into A Distribution Agreement With Eli Lilly
11.7.16 Cardinal Health Enters Into An Agreement With Monogen
11.7.17 Cardinal Health Acquires ALARIS Medical Systems
11.7.18 Microtek Medical Acquires Certain Businesses Of International Medical And Affiliates From Cardinal
11.7.19 Bespak Enters Into A Co-Marketing Agreement With Cardinal Health
11.7.20 Platinum Equity To Acquire Healthcare Marketing Services Unit Of Cardinal Health
11.7.21 Cardinal Health To Acquire Enturia
11.8 Recent Developments
11.8.1 Apr 01, 2008: Cardiac Science signs letter of intent with Misys Healthcare Systems to connect with their EMR systems
11.8.2 Mar 18, 2008: Cardinal Appoints New Chief Compliance Officer
11.8.3 Mar 13, 2008: Cardinal Names President To Its Pharmaceutical Segment
11.8.4 Feb 20, 2008: Cardiac Science Corporation Schedules Fourth Quarter Earnings Release and Announces Conference Call
11.8.5 Sep 24, 2007: Cardinal Names CEO As Chairman
11.8.6 Aug 08, 2007: Cardinal Health Elects New Director To The Board
11.8.7 Aug 08, 2007: Cardinal Health Declares Quarterly Dividend
11.8.8 Aug 08, 2007: Cardinal Health Announces Share Repurchase Program
11.8.9 May 02, 2007: Cardinal Health Elects New Director
11.8.10 May 02, 2007: Cardinal Health Increases Quarterly Dividend
11.8.11 Jan 31, 2007: Cardinal Health Declares Quarterly Dividend
11.8.12 Jan 31, 2007: Cardinal Health Announces Share Repurchase
11.8.13 Nov 10, 2006: Cardinal Health Names New CEO For Healthcare Supply Chain Services
11.8.14 Nov 08, 2006: Cardinal Health Declares Quarterly Dividend
11.8.15 Nov 08, 2006: Cardinal Health Names New Director
11.8.16 Aug 03, 2006: Cardinal Health Announces Share Repurchase Program
11.8.17 Aug 02, 2006: Cardinal Health Declares Quarterly Dividend
11.8.18 Jul 17, 2006: Cardinal Health Signs Agreement With Premier
11.8.19 Jun 12, 2006: Cardinal Health Announces Fiscal 2007 Outlook
11.8.20 May 10, 2006: Cardinal Health Raises Quarterly Dividend By 50%
11.8.21 Apr 17, 2006: Cardinal Health President and COO Leaves
11.8.22 Apr 17, 2006: Cardinal Health Appoints New President, CEO and Director
12 Covidien Ltd./Tyco Healthcare Company Profile
12.1 Company Overview
12.2 Business Overview
12.2.1 Imaging Solutions
12.2.2 Medical Devices
12.2.3 Medical Supplies
12.2.4 Pharmaceutical Products
12.2.5 Retail Products
12.2.6 Products
12.2.7 History
12.3 Value Chain Analysis
12.3.1 Manufacturing
12.3.2 Product Development
12.3.3 Sales and Marketing
12.4 SWOT Analysis
12.4.1 Covidien Ltd./Tyco Healthcare Strengths
12.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
12.4.3 Covidien Ltd./Tyco Healthcare Opportunities
12.4.4 Covidien Ltd./Tyco Healthcare Threats
12.5 Financial and Operational Review
12.5.1 Financial Statements
12.5.2 Financial Ratios
12.6 Locations And Subsidiaries
12.7 Financial Deals Landscape
12.7.1 Covidien Signs An Agreement With Allergan
12.7.2 Covidien Acquires Scandius Biomedical
12.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
12.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
12.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
12.7.6 Covidien To Sell European Incontinence Business
12.7.7 Covidien To Acquire Tissue Science Laboratories
12.8 Recent Developments
12.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
12.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
12.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
12.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
12.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
12.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
12.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
12.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
12.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
12.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
12.9 Covidien Ltd./Tyco Healthcare Pipeline Products
12.9.1 PleuraSeal Lung Sealant System
12.9.2 Sandman Intro CPAP Device
13 Sunrise Medical Company Profile
13.1 Company Overview
13.2 Business Overview
13.2.1 Products
13.2.2 History
13.3 Locations And Subsidiaries
14 Smiths Medical Company Profile
14.1 Company Overview
14.2 Business Overview
14.2.1 Products
14.2.2 History
14.2.3 Manufacturing
14.2.4 Product Development
Regulatory Approvals
14.2.5 Sales and Marketing
14.3 SWOT Analysis
14.3.1 Smiths Medical Strengths
14.3.2 Smiths Medical Weaknesses
14.3.3 Smiths Medical Opportunities
14.3.4 Smiths Medical Threats
1.5 Locations And Subsidiaries
1.6 Financial Deals Landscape
1.6.1 Smiths Medical Signs An Agreement With Inditherm
1.6.2 Smiths Medical And PHASEIN Enter Into Distribution Agreement
1.6.3 Smiths Medical Acquires DHD Healthcare
1.7 Recent Developments
1.7.1 Mar 25, 2008: Smiths Wins Agreements With MedAssets
1.7.2 Sep 26, 2007: Smiths Reports Fiscal 2007 Results
1.7.3 Sep 26, 2007: Smiths Gets New Contracts
1.7.4 Sep 21, 2007: Smiths Appoints New Vice President
1.7.5 May 09, 2007: Smiths Launch Its New Branding In China
1.7.6 Jan 19, 2006: Smiths Appoints New Managing Director
1.8 Smiths Medical Pipeline Products
1.8.1 Suction Above the Cuff ET tube (SACETT)
15 Regulation System
15.1 Medical Equipment Approval Process
15.1.1 Pre-market Approval Process
15.1.2 Intended use and Indications for use
15.1.3 Predicate Device
15.1.4 Safe and Effective
15.1.5 Other Category Devices
15.1.6 Post-Market Approval Process
15.1.7 Compliance and Enforcement
15.1.8 Registration Fee
15.1.9 Approval Time
16 Pricing and Reimbursement
16.1 Government Policies
16.2 Private Insurance
16.3 Diagnosis Related Groups (DRG)
17 Distribution Structure
17.1 Distribution Structure
18 APPENDIX
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panels
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: United States Healthcare Expenditure, 2003-2010
Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003
Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003
Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003
Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004
Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004
Table 7: Total Number of Doctors in the United States, 2003-2010
Table 8: Number of Doctors by Specialty in the United States, 2003-2010
Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)
Table 11: Total Hospitals in the United States, 2000-2004
Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004
Table 13: Number of Hospital Beds in the United States, 2000-2004
Table 14: Number of Hospital Beds by Range in the United States, 2000-2004
Table 15: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), 2000-2012
Table 16: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 17: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 18: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), 2000-2012
Table 19: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), Historic, 2000-2007
Table 20: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012
Table 21: Anesthesia and Respiratory Devices, United States, Category Volume (Units), 2000-2012
Table 22: Anesthesia and Respiratory Devices, United States, Category Volume (Units), Historic, 2000-2007
Table 23: Anesthesia and Respiratory Devices, United States, Category Volume (Units), Forecast, 2007-2012
Table 24: Anesthesia and Respiratory Devices in United States, Company Share by Revenue ($ mn), 2005-2006
Table 25: Respiratory Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 26: Respiratory Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 27: Respiratory Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007
Table 28: Respiratory Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
Table 29: Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 30: Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 31: Inhalers, United States, Overall Revenues by Sub Segment ($ mn), Forecast, 2000-2007
Table 32: Inhalers, United States, Overall Revenues by Sub Segment ($ mn), Forecast, 2007-2012
Table 33: Metered Dose Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 34: Metered Dose Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 35: Dry Powder Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 36: Dry Powder Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 37: Continuous Positive Airway Pressure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 38: Continuous Positive Airway Pressure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 39: Nebulizers, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 40: Nebulizers, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 41: Ventilators, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 42: Ventilators, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 43: Humidifiers, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 44: Humidifiers, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 45: Oxygen Concentrator, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 46: Oxygen Concentrator, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 47: Resuscitators, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 48: Resuscitators, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 49: Respiratory Devices, United States, Overall Volume (Units), Historic, 2000-2007
Table 50: Respiratory Devices, United States, Overall Volume (Units), Forecast, 2007-2012
Table 51: Inhalers, United States, Overall Volume (Units), Historic, 2000-2007
Table 52: Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012
Table 53: Inhalers by Sub Segment
Table 54: Inhalers by Sub Segment
Table 55: Metered Dose Inhalers, United States, Overall Volume (Units), Historic, 2000-2007
Table 56: Metered Dose Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012
Table 57: Dry Powder Inhalers, United States, Overall Volume (Units), Historic, 2000-2007
Table 58: Dry Powder Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012
Table 59: Nebulizers, United States, Overall Volume (Units), Historic, 2000-2007
Table 60: Nebulizers, United States, Overall Volume (Units), Forecast, 2007-2012
Table 61: Humidifiers, United States, Overall Volume (Units), Historic, 2000-2007
Table 62: Humidifiers, United States, Overall Volume (Units), Forecast, 2007-2012
Table 63: Ventilators, United States, Overall Volume (Units), Historic, 2000-2007
Table 64: Ventilators, United States, Overall Volume (Units), Forecast, 2007-2012
Table 65: Resuscitators, United States, Overall Volume (Units), Historic, 2000-2007
Table 66: Resuscitators, United States, Overall Volume (Units), Forecast, 2007-2012
Table 67: Continuous Positive Airway Pressure Devices, United States, Overall Volume (Units), Historic, 2000-2007
Table 68: Continuous Positive Airway Pressure Devices, United States, Overall Volume (Units), Forecast, 2007-2012
Table 69: Oxygen Concentrator, United States, Overall Volume (Units), Historic, 2000-2007
Table 70: Oxygen Concentrator, United States, Overall Volume (Units), Forecast, 2007-2012
Table 71: Continuous Positive Airway Pressure Devices, United States, Average Price ($), Historic, 2000-2007
Table 72: Continuous Positive Airway Pressure Devices, United States, Average Price ($), Forecast, 2007-2012
Table 73: Metered Dose Inhalers, United States, Average Price ($), Historic, 2000-2007
Table 74: Metered Dose Inhalers, United States, Average Price ($), Forecast, 2007-2012
Table 75: Dry Powder Inhalers, United States, Average Price ($), Historic, 2000-2007
Table 76: Dry Powder Inhalers, United States, Average Price ($), Forecast, 2007-2012
Table 77: Resuscitators, United States, Average Price ($), Historic, 2000-2007
Table 78: Resuscitators, United States, Average Price ($), Forecast, 2007-2012
Table 79: Ventilators, United States, Average Price ($), Historic, 2000-2007
Table 80: Ventilators, United States, Average Price ($), Forecast, 2007-2012
Table 81: Humidifiers, United States, Average Price ($), Historic, 2000-2007
Table 82: Humidifiers, United States, Average Price ($), Forecast, 2007-2012
Table 83: Nebulizers, United States, Average Price ($), Historic, 2000-2007
Table 84: Nebulizers, United States, Average Price ($), Forecast, 2007-2012
Table 85: Oxygen Concentrator, United States, Average Price ($), Historic, 2000-2007
Table 86: Oxygen Concentrator, United States, Average Price ($), Forecast, 2007-2012
Table 87: Respiratory Devices, United States, Distribution Share by Revenue ($ mn), 2005-2006
Table 88: Respiratory Devices, United States, Company Share by Revenue ($ mn), 2005-2006
Table 89: Respiratory Measurement Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 90: Respiratory Measurement Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 91: Respiratory Measurement Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007
Table 92: Respiratory Measurement Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
Table 93: Pulse Oximetry Sensors, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 94: Pulse Oximetry Sensors, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 95: Capnographs, United States, Overall Revenues ($ mn), Historic, 2000-2007

Abstract

United States Anesthesia and Respiratory Devices Industry Report

Summary

This report is an essential source for in-depth information and data relating to the USA Anesthesia & Respiratory Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Anesthesia & Respiratory Devices in USA

Scope
  • The report provides anesthesia & respiratory devices market information broken down into detailed categories and segments in United States.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008